Goldberg Michael

SEC Form 4 insider trading activity

Goldberg Michael has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.

On the most recent filing, Goldberg Michael is listed as Director at CareDx, Inc. Inside the rolling window, Goldberg Michael reported no open-market purchases and 1 open-market sale totaling $2.1M in CDNA.

Companies traded

Other insiders at CDNA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CDNASale$2.1MAug 6SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Goldberg Michael made?

Goldberg Michael has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does Goldberg Michael trade?

Goldberg Michael has filed SEC Form 4 disclosures for 1 company, including CDNA.

When was Goldberg Michael's most recent SEC Form 4 filing?

Goldberg Michael's most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.

What is Goldberg Michael's total buy and sell value in the current window?

Inside the rolling retention window, Goldberg Michael bought $0 and sold $2.1M based on SEC Form 4 filings.

What was Goldberg Michael's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 44,700 CDNA shares on 2026-08-04, worth $2.1M, per SEC Form 4 filings.